Basics Crinetics Pharmaceuticals, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.87B Activated in VL: True Average Daily Range Avg Daily Range: $0.67 | 2.72% Avg Daily Range (30 D): $0.88 | 2.93% Avg Daily Range (90 D): $0.93 | 2.67% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .8M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 2,236 Avg Inst. Trade: $2.37M Avg Inst. Trade (30 D): $2.36M Avg Inst. Trade (90 D): $2.35M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.66M Avg Closing Trade (30 D): $4.3M Avg Closing Trade (90 D): $5M Avg Closing Volume: 107.56K         News Feb 6, 2025 @ 9:35 PM Crinetics Pharmaceuticals to Report Fourth Quarter... Source: N/A Jan 10, 2025 @ 12:00 PM Crinetics Announces Positive Topline Results From ... Source: N/A Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Dec 16, 2024 @ 2:10 PM Neurocrine's Drug Gains FDA Nod As First Targeted ... Source: Vandana Singh Dec 11, 2024 @ 1:44 AM Crinetics Pharmaceuticals Announces December 2024 ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.04 $-.96 $-.94 Diluted EPS $-1.04 $-.96 $-.94 Revenue $ .36M $ M $ .4M Gross Profit $ $ $ Net Income / Loss $ -96.77M $ -76.83M $ -74.06M Operating Income / Loss $ -111.41M $ -87.8M $ -82.78M Cost of Revenue $ $ $ Net Cash Flow $ -169.98M $ 15.11M $ -93.76M PE Ratio